(Q53548352)
Statements
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. (English)
1 reference
Maria Grazia Bernengo
1 reference
Pietro Quaglino
1 reference
Alessandra Comessatti
1 reference
Michela Ortoncelli
1 reference
Mauro Novelli
1 reference
Francesco Lisa
1 reference
Maria Teresa Fierro
1 reference
1 June 2007
1 reference
1 reference
92
1 reference
6
1 reference
784-794
1 reference
Identifiers
1 reference